Effectiveness of Molnupiravir in High Risk Patients: a Propensity Score Matched Analysis.
Ronza Najjar-DebbinyNaomi GronichGabriel WeberJohad KhouryMaisam AmarNili SteinLee Hilary GoldsteinWalid SalibaPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
This study suggests that in the era of omicron and in real life setting Molnupiravir might be effective in reducing the risk of severe COVID-19 and COVID-19 related mortality, particularly in specific subgroups.